ERBB2 and breast carcinoma: One of the methods of sonication was seen to be effective in the case of breast cancer, where siRNA against HER2 was loaded, and a further reduction in the HER2 (human epidermal receptor 2) mRNA expression in the recipient cell was observed, making it a viable option for breast cancer therapy.